Z-0833-2021 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-0833-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 23, 2020 and is designated Class II. Reason for recall: The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium… The recall status is ongoing. Affected quantity: 3083 cases.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Nov 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3083 cases

Product description

Naturalyte Liquid Acid concentrate bottles, Product Code 08-2251-0 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reason for recall

The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.

Distribution pattern

US Nationwide distribution.

Code information

Lot Numbers: 20LXAC076 20LXAC077 20LXAC091 20LXAC101 20NXAC010 Additional Affected lots as of 3/17/21: 20LXAC053 20LXAC047 20LXAC054 20LXAC049 20NXAC016 20LXAC094 20NXAC024 20NXAC025 20LXAC091 20LXAC101 20LXAC077 20LXAC048 20NXAC010 20LXAC076

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0833-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0833-2021. Report a data issue: hello@regdatalab.com.